Streetbeat News

Stock Prices

AVO

CDMO

CVGW

ORCL

TSLA

Calavo Growers and several other stocks, including Tesla and Oracle, saw significant gains on Tuesday. Calavo Growers reported better-than-expected earnings and increased its dividend, leading to a 12.5% stock price increase. Mission Produce, Avid Bioservices, and Oracle also posted strong earnings, contributing to their stock price rises.

Portfolio Pulse from Avi Kapoor

September 10, 2024 | 2:07 pm

IZEA

IZEA Worldwide has partnered with GP Investments to enhance value creation, expanding its share buyback program from $5M to $10M. A new committee will evaluate strategic options, and the company is focusing on M&A for profitable growth.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 2:05 pm

PRG

Analysts have provided mixed ratings for PROG Holdings (NYSE:PRG) over the past three months, with a recent increase in the average 12-month price target to $48.8. The company's financial performance shows challenges in revenue growth and net margin, but strong ROE and ROA.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 2:01 pm

HAE

Haemonetics (NYSE:HAE) has been analyzed by four analysts, showing a range of ratings from bullish to indifferent. The average 12-month price target is $107.5, with a high of $125 and a low of $85. Recent analyst actions include a buy rating from BTIG, a neutral rating from Citigroup, and outperform ratings from JMP Securities and Barrington Research. Haemonetics has shown a revenue growth rate of 7.98% and strong financial metrics, including a net margin of 11.41% and a ROE of 4.11%.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 2:01 pm

HRMY

In the past three months, six analysts have rated Harmony Biosciences (NASDAQ:HRMY), with all ratings being bullish. The average 12-month price target remains at $52.0, with a high of $56.00 and a low of $48.00. Analysts from UBS, Needham, and Citigroup have maintained or announced 'Buy' ratings. Harmony Biosciences shows a positive revenue trend with a 28.76% growth rate, a net margin of 6.71%, and a conservative debt-to-equity ratio of 0.35.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 2:01 pm

DAVE

Analysts have evaluated Dave (NASDAQ:DAVE) over the past three months, with a mix of bullish and somewhat bullish ratings. The average 12-month price target is $60.57, a decrease from the previous $63.60. Dave has shown strong financial performance with notable revenue growth and efficient cost management, but its debt-to-equity ratio is higher than the industry average.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 2:01 pm

GWRE

Guidewire Software (NYSE:GWRE) has outperformed the market over the past 10 years with an average annual return of 14.4%, resulting in a $1000 investment growing to $3,780.88. The company's current market cap is $13.94 billion.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 2:00 pm

VRSK

Verisk Analytics (NASDAQ:VRSK) has significantly outperformed the market over the past 15 years, with an average annual return of 16.66%. A $100 investment in VRSK 15 years ago would be worth $1,009.09 today, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 2:00 pm

PAYO

Analysts have recently updated their ratings for Payoneer Global (NASDAQ:PAYO), with a majority being bullish. The average 12-month price target has increased to $8.75, reflecting a 12.9% rise. Payoneer has shown strong revenue growth but faces challenges in profitability and returns.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 2:00 pm

TDG

TransDigm Group's short interest has increased by 6.29%, with 1.86% of its shares sold short. This is below the peer group average of 2.35%. The rise in short interest may indicate bearish sentiment, but it doesn't guarantee a price drop.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 2:00 pm